CS logo
small CS logo
Boehringer Ingelheim

Ingelheim Am Rhein, Germany
Pharmaceutical company in Ingelheim am Rhein, Rhineland-Palatinate
Binger Str. 173, 55218 Ingelheim am Rhein

About Boehringer Ingelheim


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
4
Total Rows: 1

Clinical Trials at Boehringer Ingelheim


During the past decade, Boehringer Ingelheim conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years112211000000Started TrialsCompleted Trails2020202120220123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Based on Data From German Sick Funds That Looks at the Costs of Treatment of Type-2 Diabetic Patients With Empagliflozin vs. DPP-4 Inhibitors vs. GLP-1 Receptor Agonists
2020-11-16
2021-09-30
Completed
24,500
This Study Combines Data From 3 Other Studies Testing Empagliflozin in Patients With Diabetes or With Chronic Heart Failure. The Study Looks at the Numbers of Patients Who Had Lower Limb Amputations
2021-06-01
2021-07-13
Completed
14,000
A Study Based on Japanese Medical Records That Looks at Bleeding Events in People With Atrial Fibrillation and Coronary Artery Disease Who Start Taking Either Dabigatran, Rivaroxaban, or Warfarin
2022-05-17
2022-07-29
Completed
32,000
To Assess the Risk of Acute Pancreatitis in Patients With Type 2 Diabetes Mellitus Treated With Empagliflozin
2021-12-20
2022-09-12
Completed
72,621

Rows per page:

1–4 of 4

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsBoehringer Ingelheim: 4Boehringer Ingelheim: 4

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Boehringer Ingelheim


According to Clinical.Site data, the most researched conditions in "Boehringer Ingelheim" are "Diabetes Mellitus, Type 2" (3 trials), "Atrial Fibrillation" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Boehringer Ingelheim" in a lesser frequency.

Clinical Trials Intervention Types at Boehringer Ingelheim


Most popular intervention types in "Boehringer Ingelheim" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Empagliflozin" (2 trials), "DPP-4i" (1 trials), "GLP-1-RA" (1 trials), "Oral non-incretin/non-sodium glucose co-transporter-2 inhibitors (SGLT2)-containing hypoglycaemic agents" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Boehringer Ingelheim


The vast majority of trials in "Boehringer Ingelheim" are 4 trials for "All" genders.

Clinical Trials Status at Boehringer Ingelheim


Currently, there are NaN active trials in "Boehringer Ingelheim". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Boehringer Ingelheim, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Boehringer Ingelheim, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials StatusCompleted: 4Completed: 4